(Q35331225)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

1 reference

title

Understanding the role of gut microbiome in metabolic disease risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Marta Olivares

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ángela Moya-Pérez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Carlo Agostoni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1

Yolanda Sanz

1 reference

7 August 2017

Marta Olivares

2

1 reference

7 August 2017

Ángela Moya-Pérez

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

14 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

236-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

Diet, gut microbiota and immune responses

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

The marriage of nutrigenomics with the microbiome: the case of infant-associated bifidobacteria and milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Long term effect of gut microbiota transfer on diabetes development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Functional metagenomic investigations of the human intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Dissecting the in vivo metabolic potential of two human gut acetogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Understanding the role of gut microbes and probiotics in obesity: how far are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Human intestinal microbiota composition is associated with local and systemic inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Interplay between weight loss and gut microbiota composition in overweight adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Dietary intervention impact on gut microbial gene richness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut microbiota from twins discordant for obesity modulate metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

The pioneer gut microbiota in human neonates vaginally born at term-a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Molecular characterisation of the faecal microbiota in patients with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut metagenome in European women with normal, impaired and diabetic glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Endotoxemia is associated with an increased risk of incident diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Immune modulation in humans: implications for type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Toward defining the autoimmune microbiome for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Differences in the gut microbiota of healthy children and those with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Does breastfeeding influence the risk of developing diabetes mellitus in children? A review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Celiac disease associated with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Microbiota, inflammation and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Early differences in fecal microbiota composition in children may predict overweight.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Increased intestinal permeability precedes clinical onset of type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.170

31 March 2020

Identifiers

DOI

10.1038/PR.2014.170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25314581%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference